179 related articles for article (PubMed ID: 30362476)
1. Acid-active supramolecular anticancer nanoparticles based on cyclodextrin polyrotaxanes damaging both mitochondria and nuclei of tumor cells.
Bai S; Zhang X; Ma X; Chen J; Chen Q; Shi X; Hou M; Xue P; Kang Y; Xu Z
Biomater Sci; 2018 Nov; 6(12):3126-3138. PubMed ID: 30362476
[TBL] [Abstract][Full Text] [Related]
2. Folate-mediated mitochondrial targeting with doxorubicin-polyrotaxane nanoparticles overcomes multidrug resistance.
Wang H; Yin H; Yan F; Sun M; Du L; Peng W; Li Q; Feng Y; Zhou Y
Oncotarget; 2015 Feb; 6(5):2827-42. PubMed ID: 25605018
[TBL] [Abstract][Full Text] [Related]
3. Reduction-active polymeric prodrug micelles based on α-cyclodextrin polyrotaxanes for triggered drug release and enhanced cancer therapy.
Bai S; Hou M; Shi X; Chen J; Ma X; Gao YE; Wang Y; Xue P; Kang Y; Xu Z
Carbohydr Polym; 2018 Aug; 193():153-162. PubMed ID: 29773367
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of a Pillar[5]arene-Based Polyrotaxane for Enhancing the Drug Loading Capacity of PCL-Based Supramolecular Amphiphile as an Excellent Drug Delivery Platform.
He J; Chen J; Lin S; Niu D; Hao J; Jia X; Li N; Gu J; Li Y; Shi J
Biomacromolecules; 2018 Jul; 19(7):2923-2930. PubMed ID: 29787265
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumor drug delivery system based on cyclodextrin-containing pH-responsive star polymer: in vitro and in vivo evaluation.
Xiong Q; Zhang M; Zhang Z; Shen W; Liu L; Zhang Q
Int J Pharm; 2014 Oct; 474(1-2):232-40. PubMed ID: 25149124
[TBL] [Abstract][Full Text] [Related]
6. Polyrotaxane-based supramolecular theranostics.
Yu G; Yang Z; Fu X; Yung BC; Yang J; Mao Z; Shao L; Hua B; Liu Y; Zhang F; Fan Q; Wang S; Jacobson O; Jin A; Gao C; Tang X; Huang F; Chen X
Nat Commun; 2018 Feb; 9(1):766. PubMed ID: 29472567
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate-based amphiphilic prodrug nanoaggregates for co-administration of multiple therapeutics and synergistic cancer therapy.
Hou M; Gao YE; Shi X; Bai S; Ma X; Li B; Xiao B; Xue P; Kang Y; Xu Z
Acta Biomater; 2018 Sep; 77():228-239. PubMed ID: 30006314
[TBL] [Abstract][Full Text] [Related]
8. Robust, active tumor-targeting and fast bioresponsive anticancer nanotherapeutics based on natural endogenous materials.
Sun B; Deng C; Meng F; Zhang J; Zhong Z
Acta Biomater; 2016 Nov; 45():223-233. PubMed ID: 27576338
[TBL] [Abstract][Full Text] [Related]
9. Efficient delivery of antitumor drug to the nuclei of tumor cells by amphiphilic biodegradable poly(L-aspartic acid-co-lactic acid)/DPPE co-polymer nanoparticles.
Han S; Liu Y; Nie X; Xu Q; Jiao F; Li W; Zhao Y; Wu Y; Chen C
Small; 2012 May; 8(10):1596-606. PubMed ID: 22411637
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
[TBL] [Abstract][Full Text] [Related]
11. Supramolecular nanoparticles generated by the self-assembly of polyrotaxanes for antitumor drug delivery.
Liu R; Lai Y; He B; Li Y; Wang G; Chang S; Gu Z
Int J Nanomedicine; 2012; 7():5249-58. PubMed ID: 23055732
[TBL] [Abstract][Full Text] [Related]
12. Enzyme and Thermal Dual Responsive Amphiphilic Polymer Core-Shell Nanoparticle for Doxorubicin Delivery to Cancer Cells.
Kashyap S; Singh N; Surnar B; Jayakannan M
Biomacromolecules; 2016 Jan; 17(1):384-98. PubMed ID: 26652038
[TBL] [Abstract][Full Text] [Related]
13. Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy.
Liu Y; Qiao L; Zhang S; Wan G; Chen B; Zhou P; Zhang N; Wang Y
Acta Biomater; 2018 Jan; 66():310-324. PubMed ID: 29129789
[TBL] [Abstract][Full Text] [Related]
14. Improving the carrier stability and drug loading of unimolecular micelle-based nanotherapeutics for acid-activated drug delivery and enhanced antitumor therapy.
Shi X; Bai S; Yang C; Ma X; Hou M; Chen J; Xue P; Li CM; Kang Y; Xu Z
J Mater Chem B; 2018 Sep; 6(35):5549-5561. PubMed ID: 32254965
[TBL] [Abstract][Full Text] [Related]
15. Starburst Diblock Polyprodrugs: Reduction-Responsive Unimolecular Micelles with High Drug Loading and Robust Micellar Stability for Programmed Delivery of Anticancer Drugs.
Shi X; Hou M; Ma X; Bai S; Zhang T; Xue P; Zhang X; Liu G; Kang Y; Xu Z
Biomacromolecules; 2019 Mar; 20(3):1190-1202. PubMed ID: 30658038
[TBL] [Abstract][Full Text] [Related]
16. In vitro assessment of a novel polyrotaxane-based drug delivery system integrated with a cell-penetrating peptide.
Moon C; Kwon YM; Lee WK; Park YJ; Yang VC
J Control Release; 2007 Dec; 124(1-2):43-50. PubMed ID: 17904680
[TBL] [Abstract][Full Text] [Related]
17. Biocompatible cationic pullulan-g-desoxycholic acid-g-PEI micelles used to co-deliver drug and gene for cancer therapy.
Chen L; Ji F; Bao Y; Xia J; Guo L; Wang J; Li Y
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):418-429. PubMed ID: 27770912
[TBL] [Abstract][Full Text] [Related]
18. Specific Modification with TPGS and Drug Loading of Cyclodextrin Polyrotaxanes and the Enhanced Antitumor Activity Study in Vitro and in Vivo.
Zhang Y; Zhou Q; Jia S; Lin K; Fan G; Yuan J; Yu S; Shi J
ACS Appl Mater Interfaces; 2019 Dec; 11(50):46427-46436. PubMed ID: 31762252
[TBL] [Abstract][Full Text] [Related]
19. Mitochondria and nuclei dual-targeted heterogeneous hydroxyapatite nanoparticles for enhancing therapeutic efficacy of doxorubicin.
Xiong H; Du S; Ni J; Zhou J; Yao J
Biomaterials; 2016 Jul; 94():70-83. PubMed ID: 27105438
[TBL] [Abstract][Full Text] [Related]
20. Development of self-assembled multi-arm polyrotaxanes nanocarriers for systemic plasmid delivery in vivo.
Ji Y; Liu X; Huang M; Jiang J; Liao YP; Liu Q; Chang CH; Liao H; Lu J; Wang X; Spencer MJ; Meng H
Biomaterials; 2019 Feb; 192():416-428. PubMed ID: 30500723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
